Literature DB >> 19877828

Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation.

Zhilei Lu1, Weiyang Chen, Josias H Hamman.   

Abstract

PURPOSE: It was previously shown in our laboratories that the interpolyelectrolyte complex between chitosan and polycarbophil has promise as a matrix former to control the release of water-soluble drugs. This study further investigates the applications of this polymeric complex to produce controlled release matrices for poorly water-soluble drugs.
METHODS: The swelling, erosion, and drug release performance of matrix-type tablets containing the chitosan-polycarbophil complex as matrix former was compared to those consisting of hydroxypropylmethylcellulose and a simple mixture of chitosan and polycarbophil powders.
RESULTS: The chitosan-polycarbophil complex matrices showed good swelling with relatively low erosion and slower drug release compared to those prepared from other polymeric materials. They also exhibited release exponent (n) values closer to unity and therefore to zero-order release compared to the other matrices.
CONCLUSIONS: The chitosan-polycarbophil complex formed matrix-type tablets that controlled the release of poorly water-soluble drugs approaching zero-order kinetics. The mechanism of drug release was mainly diffusion from swollen systems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19877828     DOI: 10.3109/03639040903315579

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Minocycline hydrochloride nanoliposomes inhibit the production of TNF-α in LPS-stimulated macrophages.

Authors:  D Liu; P S Yang
Journal:  Int J Nanomedicine       Date:  2012-08-31

2.  Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-fluorouracil formulations for buccal, vaginal and rectal application.

Authors:  Mohamed S Pendekal; Pramod K Tegginamat
Journal:  Daru       Date:  2012-10-25       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.